Acrivon Therapeutics, Inc. ($ACRV)
Filing Information
| Accession Number | 0000905148-26-001118 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 3, 2026 |
| Document | View SEC Filing |
Transactions
1
Total Shares
132,925
Total Value
$0.00
P&L
+inf% (+$220,655.50)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Stock Option (Right to Buy) | Derivative | Mar 1, 2026 | Grant/Award | 132,925 | $0.00 | $0.00 | 132,925 | Direct | โ | View Details |